Ardavan Abiri
Impact in
-
- vaccines and immunoinformatics approaches
- DNA and Nucleic Acid Chemistry
-
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- vaccines and immunoinformatics approaches 3
-
- Synthesis and biological activity 5
- Click Chemistry and Applications 2
- Co-authors
- Ashkan Safavi (3 shared papers)Amirhosein Kefayat (3 shared papers)Fatemeh Ghahremani (2 shared papers)Khalil Eskandari (4 shared papers)Yaghoub Pourshojaei (5 shared papers)Ali Asadipour (4 shared papers)Najmeh Edraki (1 shared paper)Zahra Haghighijoo (1 shared paper)
- Journals
- Medicinal Chemistry Research (2 papers)Analytical Biochemistry (2 papers)Biotechnology and Applied Biochemistry (1 paper)Current Medicinal Chemistry (1 paper)PLoS ONE (1 paper)
- Partner nations
- IranUnited StatesGeorgia
In The Last Decade
Ardavan Abiri
29 papers receiving 637 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 403
- Infectious Diseases 93
- Immunology 101
- Pharmacology 78
- Computational Theory and Mathematics 75
Countries citing papers authored by Ardavan Abiri
This map shows the geographic impact of Ardavan Abiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ardavan Abiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ardavan Abiri more than expected).
Fields of papers citing papers by Ardavan Abiri
This network shows the impact of papers produced by Ardavan Abiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ardavan Abiri. The network helps show where Ardavan Abiri may publish in the future.
Co-authors
The 25 scholars most cited alongside Ardavan Abiri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 104 | |
| 2 | 2019 | 82 | |
| 3 | 2021 | 74 | |
| 4 | 2019 | 72 | |
| 5 | 2021 | 57 | |
| 6 | 2019 | 56 | |
| 7 | 2020 | 39 | |
| 8 | 2020 | 30 | |
| 9 | 2019 | 16 | |
| 10 | 2022 | 14 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2020 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2020 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2024 | 3 |
About Ardavan Abiri
Ardavan Abiri is a scholar working on Molecular Biology, Organic Chemistry, Computational Theory and Mathematics, Immunology and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 640 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Research on Leishmaniasis Studies (3 papers), Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (3 papers), Click Chemistry and Applications (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Molecular Biology (403 citations), Infectious Diseases (93 citations), Immunology (101 citations), Pharmacology (78 citations) and Computational Theory and Mathematics (75 citations). Ardavan Abiri has collaborated with scholars based in Iran, United States and Georgia. Frequent co-authors include Ashkan Safavi, Amirhosein Kefayat, Fatemeh Ghahremani, Khalil Eskandari, Yaghoub Pourshojaei, Ali Asadipour, Najmeh Edraki, Zahra Haghighijoo, Payman Zare and Jean‐Louis Mergny. Their work appears in journals such as Medicinal Chemistry Research, Analytical Biochemistry, Biotechnology and Applied Biochemistry, Current Medicinal Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.